Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jörgen Carlsson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Anatomy
Disorders
Chemicals & Drugs
Procedures
Concepts & Ideas
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
28
Tolmachev, Vladimir
26
Lundqvist, Hans
25
Gedda, Lars
15
Blomquist, Erik
15
Sjöberg, Stefan
13
Stenerlöw, Bo
12
Sundin, Anders
12
Olsson, Pär
11
Orlova, Anna
11
Glimelius, Bengt
10
Lövqvist, A
9
Capala, Jacek
9
Acker, Helmut
8
Grusell, Erik
8
Sundberg, Asa Liljegren
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jörgen Carlsson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Qvarnström O F; Simonsson M; Eriksson V; Turesson I; Carlsson J
gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids.
International journal of oncology 2009;35(1):41-7.
-
2008: Ekerljung Lina; Lindborg Malin; Gedda Lars; Frejd Fredrik Y; Carlsson Jörgen; Lennartsson Johan
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line.
Biochemical and biophysical research communications 2008;377(2):489-94.
-
2008: Segerström Lova; Stenerlow Bo; Eriksson Veronika; Carlsson Jörgen
Effects of radiation on growth of two human tumour cell lines surviving a previous high dose, low dose-rate, radionuclide exposure.
International journal of oncology 2008;33(2):341-9.
-
2008: Steffen Ann-Charlott; Göstring Lovisa; Tolmachev Vladimir; Palm Stig; Stenerlöw Bo; Carlsson Jörgen
Differences in radiosensitivity between three HER2 overexpressing cell lines.
European journal of nuclear medicine and molecular imaging 2008;35(6):1179-91.
-
2008: Enger S A; Hartman T; Carlsson J; Lundqvist H
Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics.
Physics in medicine and biology 2008;53(7):1909-20.
-
2008: Nordberg E; Orlova A; Friedman M; Tolmachev V; Ståhl S; Nilsson F Y; Glimelius B; Carlsson J
In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.
Oncology reports 2008;19(4):853-7.
-
2007: Nordberg Erika; Friedman Mikaela; Göstring Lovisa; Adams Gregory P; Brismar Hjalmar; Nilsson Fredrik Y; Ståhl Stefan; Glimelius Bengt; Carlsson Jörgen
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
Nuclear medicine and biology 2007;34(6):609-18.
-
2007: Steffen Ann-Charlott; Almqvist Ylva; Chyan Ming-Kuan; Lundqvist Hans; Tolmachev Vladimir; Wilbur D Scott; Carlsson Jörgen
Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
Oncology reports 2007;17(5):1141-7.
-
2007: Tolmachev Vladimir; Orlova Anna; Pehrson Rikard; Galli Joakim; Baastrup Barbro; Andersson Karl; Sandström Mattias; Rosik Daniel; Carlsson Jörgen; Lundqvist Hans; Wennborg Anders; Nilsson Fredrik Y
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
Cancer research 2007;67(6):2773-82.
-
2007: Persson Mikael; Gedda Lars; Lundqvist Hans; Tolmachev Vladimir; Nordgren Hans; Malmström Per-Uno; Carlsson Jörgen
[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts.
Cancer research 2007;67(1):326-31.
-
2007: Monazzam Azita; Josephsson Raymond; Blomqvist Carl; Carlsson Jörgen; Långström Bengt; Bergström Mats
Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.
Breast cancer research : BCR 2007;9(4):R45.
-
2006: Carlsson Jörgen; Eriksson Veronika; Stenerlöw Bo; Lundqvist Hans
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
European journal of nuclear medicine and molecular imaging 2006;33(10):1185-95.
-
2006: Ickenstein Ludger M; Edwards Katarina; Sjöberg Stefan; Carlsson Jörgen; Gedda Lars
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy.
Nuclear medicine and biology 2006;33(6):773-83.
-
2006: Steffen Ann-Charlott; Orlova Anna; Wikman Maria; Nilsson Fredrik Y; Ståhl Stefan; Adams Gregory P; Tolmachev Vladimir; Carlsson Jörgen
Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.
European journal of nuclear medicine and molecular imaging 2006;33(6):631-8.
-
2006: Orlova Anna; Magnusson Mikaela; Eriksson Tove L J; Nilsson Martin; Larsson Barbro; Höidén-Guthenberg Ingmarie; Widström Charles; Carlsson Jörgen; Tolmachev Vladimir; Ståhl Stefan; Nilsson Fredrik Y
Tumor imaging using a picomolar affinity HER2 binding affibody molecule.
Cancer research 2006;66(8):4339-48.
-
2006: Orlova Anna; Nilsson Fredrik Y; Wikman Maria; Widström Charles; Ståhl Stefan; Carlsson Jörgen; Tolmachev Vladimir
Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):512-9.
-
2006: Carlsson J; Ren Z P; Wester K; Sundberg A L; Heldin N E; Hesselager G; Persson M; Gedda L; Tolmachev V; Lundqvist H; Blomquist E; Nistér M
Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.
Journal of neuro-oncology 2006;77(1):33-45.
-
2006: Ekerljung Lina; Steffen Ann-Charlott; Carlsson Jorgen; Lennartsson Johan
Effects of HER2-binding affibody molecules on intracellular signaling pathways.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(4):201-10.
-
2005: Persson Mikael; Tolmachev Vladimir; Andersson Karl; Gedda Lars; Sandström Mattias; Carlsson Jörgen
[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.
European journal of nuclear medicine and molecular imaging 2005;32(12):1457-62.
-
2005: Velikyan Irina; Sundberg Asa Liljegren; Lindhe Orjan; Höglund A Urban; Eriksson Olof; Werner Eva; Carlsson Jorgen; Bergström Mats; Långström Bengt; Tolmachev Vladimir
Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1881-8.
-
2005: Nordberg Erika; Steffen Ann-Charlott; Persson Mikael; Sundberg Asa L; Carlsson Jörgen; Glimelius Bengt
Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.
European journal of nuclear medicine and molecular imaging 2005;32(7):771-7.
-
2005: Steffen Ann-Charlott; Wikman Maria; Tolmachev Vladimir; Adams Gregory P; Nilsson Fredrik Y; Ståhl Stefan; Carlsson Jörgen
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.
Cancer biotherapy & radiopharmaceuticals 2005;20(3):239-48.
-
2005: Gårdmark Truls; Wester Kenneth; De la Torre Manuel; Carlsson Jörgen; Malmström Per-Uno
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
BJU international 2005;95(7):982-6.
-
2004: Orlova Anna; Sjöstrom Anna; Lebeda Ondrej; Lundqvist Hans; Carlsson Jorgen; Tolmachev Vladimir
Targeting against epidermal growth factor receptors. Cellular processing of astatinated EGF after binding to cultured carcinoma cells.
Anticancer research 2004;24(6):4035-41.
-
2004: Tolmachev Vladimir; Orlova Anna; Wei Qichun; Bruskin Alexander; Carlsson Jörgen; Gedda Lars
Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):491-501.
-
2004: Sundberg Asa Liljegren; Gedda Lars; Orlova Anna; Bruskin Alexander; Blomquist Erik; Carlsson Jörgen; Tolmachev Vladimir
[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):195-204.
-
2004: Lundqvist Hans; Carlsson Jörgen; Gedda Lars; Tolmachev Vladimir; Garske Ulrike; Kairemo Kalevi
[Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use]
Läkartidningen 2004;101(11):1000-2, 1005-6.
-
2004: Bruskin Alexander; Sivaev Igor; Persson Mikael; Lundqvist Hans; Carlsson Jörgen; Sjöberg Stefan; Tolmachev Vladimir
Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI).
Nuclear medicine and biology 2004;31(2):205-11.
-
2004: Tolmachev Vladimir; Carlsson Jörgen; Lundqvist Hans
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.
Acta oncologica (Stockholm, Sweden) 2004;43(3):264-75.
-
2003: Sundberg Asa Liljegren; Almqvist Ylva; Orlova Anna; Blomquist Erik; Jensen Holger J; Gedda Lars; Tolmachev Vladimir; Carlsson Jörgen
Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.
European journal of nuclear medicine and molecular imaging 2003;30(10):1348-56.
-
2003: Carlsson Jörgen; Håkansson Emma; Eriksson Veronika; Grawe Jan; Wester Kenneth; Grusell Erik; Montelius Anders; Lundqvist Hans
Early effects of low dose-rate radiation on cultured tumor cells.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):663-70.
-
2003: Sundberg Asa Liljegren; Orlova Anna; Bruskin Alexander; Gedda Lars; Carlsson Jörgen; Blomquist Erik; Lundqvist Hans; Tolmachev Vladimir
[(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):643-54.
-
2003: Bohl Kullberg Erika; Carlsson Jörgen; Edwards Katarina; Capala Jacek; Sjöberg Stefan; Gedda Lars
Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
International journal of oncology 2003;23(2):461-7.
-
2003: Sundberg Asa Liljegren; Almqvist Ylva; Tolmachev Vladimir; Carlsson Jörgen
Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition.
European journal of nuclear medicine and molecular imaging 2003;30(5):727-9.
-
2003: Sundberg Asa Liljegren; Blomquist Erik; Carlsson Jörgen; Steffen Ann-Charlott; Gedda Lars
Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran.
Nuclear medicine and biology 2003;30(3):303-15.
-
2003: Carlsson Jörgen; Kullberg Erika Bohl; Capala Jacek; Sjöberg Stefan; Edwards Katarina; Gedda Lars
Ligand liposomes and boron neutron capture therapy.
Journal of neuro-oncology 2003;62(1-2):47-59.
-
2003: Carlsson Jörgen; Forssell Aronsson Eva; Hietala Sven Ola; Stigbrand Torgny; Tennvall Jan
Tumour therapy with radionuclides: assessment of progress and problems.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;66(2):107-17.
-
2003: Turesson Ingela; Carlsson Jörgen; Brahme Anders; Glimelius Bengt; Zackrisson Björn; Stenerlöw Bo;
Biological response to radiation therapy.
Acta oncologica (Stockholm, Sweden) 2003;42(2):92-106.
-
2003: Johansson Karl-Axel; Mattsson Sören; Brahme Anders; Carlsson Jörgen; Zackrisson Björn; Turesson Ingela;
Radiation therapy dose delivery.
Acta oncologica (Stockholm, Sweden) 2003;42(2):85-91.
-
2002: Bohl Kullberg Erika; Bergstrand Nill; Carlsson Jörgen; Edwards Katarina; Johnsson Markus; Sjöberg Stefan; Gedda Lars
Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents.
Bioconjugate chemistry 2002;13(4):737-43.
-
2002: Olsson Pär; Collins V Peter; Liu Lu; Gedda Lars; Liljegren Asa; Carlsson Jörgen
Internalisation and retention of EGF-dextran associated radioactivity in transfected Chinese hamster ovary cells expressing the human EGF-receptor.
International journal of oncology 2002;20(5):1057-63.
-
2002: Ohman Linda; Gedda Lars; Hesselager Göran; Larsson Rolf; Nister Monica; Stigbrand Torgny; Wester Kenneth; Carlsson Jörgen
A new antibody recognizing the vIII mutation of human epidermal growth factor receptor.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2002;23(2):61-9.
-
2002: Carlsson Jörgen; Forssell-Aronsson Eva; Glimelius Bengt;
Radiation therapy through activation of stable nuclides.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):629-34.
-
2002: Carlsson Jörgen; Forssell-Aronsson Eva; Glimelius Bengt; Mattsson Sören;
Therapy with radiopharmaceuticals.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):623-8.
-
2002: Zackrisson Björn; Kjellén Elisabeth; Glimelius Bengt; Carlsson Jörgen; Littbrand Bo; Turesson Ingela;
Sensitizing and protective substances in radiation therapy and predictive assays.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):615-22.
-
2002: Mattsson Sören; Brahme Anders; Carlsson Jörgen; Denekamp Juliana; Forssell-Aronsson Eva; Hellström Mikael; Johansson Karl-Axel; Kjellén Elisabeth; Littbrand Bo; Nordenskjöld Bo; Stenerlöw Bo; Turesson Ingela; Zackrisson Björn; Glimelius Bengt;
Swedish Cancer Society radiation therapy research investigation.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):596-603.
-
2002: Stenerlow B; Hoglund E; Carlsson J
DNA fragmentation by charged particle tracks.
Advances in space research : the official journal of the Committee on Space Research (COSPAR) 2002;30(4):859-63.
-
2002: Wester Kenneth; Sjöström Anna; de la Torre Manuel; Carlsson Jörgen; Malmström Per-Uno
HER-2--a possible target for therapy of metastatic urinary bladder carcinoma.
Acta oncologica (Stockholm, Sweden) 2002;41(3):282-8.
-
2001: Frisk P; Yaqob A; Nilsson K; Carlsson J; Lindh U
Influence of selenium on mercuric chloride cellular uptake and toxicity indicating protection: studies on cultured K-562 cells.
Biological trace element research 2001;81(3):229-44.
-
2001: Nilsson P; Gedda L; Sjöström A; Carlsson J
Effects of dextranation on the uptake of peptides in micrometastases: studies on binding of EGF in tumor spheroids.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(4):229-38.
-
2000: Frisk P; Yaqob A; Nilsson K; Carlsson J; Lindh U
Uptake and retention of selenite and selenomethionine in cultured K-562 cells.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2000;13(3):209-15.
-
2000: Sjöström A; Bue P; Malmstrom P; Carlsson J
Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids.
International journal of oncology 2000;17(3):559-64.
-
2000: Gedda L; Ghaneolhosseini H; Nilsson P; Nyholm K; Pettersson J; Sjöberg S; Carlsson J
The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroids.
Anti-cancer drug design 2000;15(4):277-86.
-
2000: Frisk P; Yaqob A; Nilsson K; Carlsson J; Lindh U
Differences in the growth inhibition of cultured K-562 cells by selenium, mercury or cadmium in two tissue culture media (RPMI-1640, Ham's F-10).
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2000;13(2):101-11.
-
2000: Stenerlöw B; Höglund E; Carlsson J; Blomquist E
Rejoining of DNA fragments produced by radiations of different linear energy transfer.
International journal of radiation biology 2000;76(4):549-57.
-
2000: Höglund E; Blomquist E; Carlsson J; Stenerlöw B
DNA damage induced by radiation of different linear energy transfer: initial fragmentation.
International journal of radiation biology 2000;76(4):539-47.
-
2000: Hartman T; Lundqvist H; Westlin J E; Carlsson J
Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies.
International journal of radiation oncology, biology, physics 2000;46(4):1025-36.
-
1999: Sundin J; Tolmachev V; Koziorowski J; Carlsson J; Lundqvist H; Welt S; Larson S; Sundin A
High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T.
Nuclear medicine and biology 1999;26(8):923-9.
-
1999: Zhao Q; Tolmachev V; Carlsson J; Lundqvist H; Sundin J; Janson J C; Sundin A
Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF.
Bioconjugate chemistry 1999;10(6):938-46.
-
1999: Stenerlöw B; Höglund E; Carlsson J
Induction and rejoining of large DNA fragments after ion irradiation.
Radiation research 1999;151(6):642-8.
-
1999: Tolmachev V; Koziorowski J; Sivaev I; Lundqvist H; Carlsson J; Orlova A; Gedda L; Olsson P; Sjöberg S; Sundin A
Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.
Bioconjugate chemistry 1999;10(3):338-45.
-
1999: Lövqvist A; Lundqvist H; Lubberink M; Tolmachev V; Carlsson J; Sundin A
Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
Medical physics 1999;26(2):249-58.
-
1999: Tilly N; Brahme A; Carlsson J; Glimelius B
Comparison of cell survival models for mixed LET radiation.
International journal of radiation biology 1999;75(2):233-43.
-
1999: Lubberink M; Lundqvist H; Westlin J E; Tolmachev V; Schneider H; Lövqvist A; Sundin A; Carlsson J
Positron emission tomography and radioimmunotargeting--aspects of quantification and dosimetry.
Acta oncologica (Stockholm, Sweden) 1999;38(3):343-9.
-
1999: Lundqvist H; Lubberink M; Tolmachev V; Lövqvist A; Sundin A; Beshara S; Bruskin A; Carlsson J; Westlin J E
Positron emission tomography and radioimmunotargeting--general aspects.
Acta oncologica (Stockholm, Sweden) 1999;38(3):335-41.
-
1999: Carlsson J; Blomquist E; Gedda L; Liljegren A; Malmström P U; Sjöström A; Sundin A; Westlin J E; Zhao Q; Tolmachev V; Lundqvist H
Conjugate chemistry and cellular processing of EGF-dextran.
Acta oncologica (Stockholm, Sweden) 1999;38(3):313-21.
-
1998: Olsson P; Gedda L; Goike H; Liu L; Collins V P; Pontén J; Carlsson J
Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expression.
Anti-cancer drug design 1998;13(4):279-89.
-
1998: Bue P; Wester K; Sjöström A; Holmberg A; Nilsson S; Carlsson J; Westlin J E; Busch C; Malmström P U
Expression of epidermal growth factor receptor in urinary bladder cancer metastases.
International journal of cancer. Journal international du cancer 1998;76(2):189-93.
-
1998: Mahteme H; Lövqvist A; Graf W; Lundqvist H; Carlsson J; Sundin A
Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
Anticancer research 1998;18(2A):843-8.
-
1998: Olsson P; Black M; Capala J; Coderre J; Hartman T; Makar M; Malmquist J; Pettersson J; Tilly N; Sjöberg S; Carlsson J
Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells.
International journal of radiation biology 1998;73(1):103-12.
-
1997: Gedda L; Silvander M; Sjöberg S; Tjarks W; Carlsson J
Cytotoxicity and subcellular localization of boronated phenanthridinium analogues.
Anti-cancer drug design 1997;12(8):671-85.
-
1997: Zhao Q; Gottschalk I; Carlsson J; Arvidsson L E; Oscarsson S; Medin A; Ersson B; Janson J C
Preparation and purification of an end to end coupled mEGF-dextran conjugate.
Bioconjugate chemistry 1997;8(6):927-34.
-
1997: Frisk P; Saetre A; Couce B; Stenerlöw B; Carlsson J; Lindh U
Effects of Pb2+, Ni2+, Hg2+ and Se4+ on cultured cells. Analysis of uptake, toxicity and influence on radiosensitivity.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 1997;10(4):263-70.
-
1997: Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(7):1029-35.
-
1997: Sjöberg S; Carlsson J; Ghaneolhosseini H; Gedda L; Hartman T; Malmquist J; Naeslund C; Olsson P; Tjarks W
Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
Journal of neuro-oncology 1997;33(1-2):41-52.
-
1997: Lövqvist A; Sundin A; Ahlström H; Carlsson J; Lundqvist H
Pharmacokinetics and experimental PET imaging of a bromine-76-labeled monoclonal anti-CEA antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):395-401.
-
1997: Sjöström A; Bue P; Malmström P U; Nilsson S; Carlsson J
Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines.
International journal of cancer. Journal international du cancer 1997;70(4):383-9.
-
1996: Stenerlöw B; Blomquist E; Grusell E; Hartman T; Carlsson J
Rejoining of DNA double-strand breaks induced by accelerated nitrogen ions.
International journal of radiation biology 1996;70(4):413-20.
-
1996: Essand M; Lögdahl P; Nilsson S; Wartenberg M; Acker H; Carlsson J
Retention and processing of the monoclonal anti-prostate E4 antibody after binding to prostatic adenocarcinoma DU 145 cells.
Cancer immunology, immunotherapy : CII 1996;43(1):39-43.
-
1996: Gedda L; Olsson P; Pontén J; Carlsson J
Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy.
Bioconjugate chemistry 1996;7(5):584-91.
-
1996: Tilly N; Olsson P; Hartman T; Coderre J; Makar M; Malmquist J; Sjöberg S; Pettersson J; Carlsson J; Glimelius B
In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(1):41-50.
-
1996: Grönvik C; Capala J; Carlsson J
The non-variation in radiosensitivity of different proliferative states of human glioma cells.
Anticancer research 1996;16(1):25-31.
-
1995: Essand M; Grönvik C; Hartman T; Carlsson J
Radioimmunotherapy of prostatic adenocarcinomas: effects of 131I-labelled E4 antibodies on cells at different depth in DU 145 spheroids.
International journal of cancer. Journal international du cancer 1995;63(3):387-94.
-
1995: Stenerlöw B; Pettersson O A; Essand M; Blomquist E; Carlsson J
Irregular variations in radiation sensitivity when the linear energy transfer is increased.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;36(2):133-42.
-
1995: Carlsson J; Stenerlöw B; Russell K R; Grusell E; Larsson B; Blomquist E
Cell type dependent effectiveness of tumour cell inactivation by radiation with increased ionisation density.
Anticancer research 1995;15(2):273-82.
-
1995: Lövqvist A; Sundin A; Ahlström H; Carlsson J; Lundqvist H
76Br-labeled monoclonal anti-CEA antibodies for radioimmuno positron emission tomography.
Nuclear medicine and biology 1995;22(1):125-31.
-
1994: Carlsson J; Gedda L; Grönvik C; Hartman T; Lindström A; Lindström P; Lundqvist H; Lövqvist A; Malmqvist J; Olsson P
Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor.
International journal of radiation oncology, biology, physics 1994;30(1):105-15.
-
1994: Stenerlöw B; Carlsson J; Blomquist E; Erixon K
Clonogenic cell survival and rejoining of DNA double-strand breaks: comparisons between three cell lines after photon or He ion irradiation.
International journal of radiation biology 1994;65(6):631-9.
-
1994: Hartman T; Carlsson J
Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;31(1):61-75.
-
1994: Gáti I; Bergström M; Muhr C; Carlsson J
Leukotriene and 5-lipoxygenase inhibitor induced variations in thymidine uptake in a human glioma cell line cultured as monolayers or as multicellular spheroids.
Anticancer research 1994;14(2A):453-9.
-
1994: Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Anti-cancer drugs 1994;5(1):43-52.
-
1994: Olsson P; Lindström A; Carlsson J
Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells.
International journal of cancer. Journal international du cancer 1994;56(4):529-37.
-
1994: Capala J; Acker H; Lindström A; Carlsson J
Effects of epidermal growth factor receptor blocking in cultured glioma spheroids.
Anticancer research 1994;14(1A):45-53.
-
1994: Carlsson J; Hartman T; Grusell E
Dose enhancement in fast neutron tumour therapy due to neutron captures in 10B.
Acta oncologica (Stockholm, Sweden) 1994;33(3):315-22.
-
1994: Pettersson O A; Olsson P; Lindström P; Sjöberg S; Larsson B S; Carlsson J
Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
Acta oncologica (Stockholm, Sweden) 1994;33(6):685-91.
-
1993: Pettersson O A; Olsson P; Lindström P; Sjöberg S; Carlsson J
Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids.
Melanoma research 1993;3(5):369-76.
-
1993: Essand M; Nilsson S; Carlsson J
Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
Anticancer research 1993;13(5A):1261-8.
-
1993: Blomquist E; Russell K R; Stenerlöw B; Montelius A; Grusell E; Carlsson J
Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell lines.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(1):44-51.
-
1993: Lövqvist A; Emanuelsson H; Nilsson J; Lundqvist H; Carlsson J
Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives.
Journal of internal medicine 1993;233(3):215-26.
-
1993: Rosengren B; Wulff L; Carlsson E; Carlsson J; Strid K G; Montelius A
Backscatter radiation at tissue-titanium interfaces. Biological effects from diagnostic 65 kVp x-rays.
Acta oncologica (Stockholm, Sweden) 1993;32(1):73-7.
-
1993: Sundin A; Ahlström H; Carlsson L; Graf W; Glimelius B; Carlsson J
Radioimmunolocalization of hepatic metastases and subcutaneous xenografts from a human colonic cancer in the nude rat. Aspects of tumour implantation site and mode of antibody administration.
Acta oncologica (Stockholm, Sweden) 1993;32(7-8):877-85.
-
1993: Lövqvist A; Lindström A; Carlsson J
Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells.
Cancer biotherapy 1993;8(4):345-56.
-
1993: Lindström A; Carlsson J
Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin.
Cancer biotherapy 1993;8(2):145-58.
-
1992: Andersson A; Capala J; Carlsson J
Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
Journal of neuro-oncology 1992;14(3):213-23.
-
1992: Acker H; Holtermann G; Bölling B; Carlsson J
Influence of glucose on metabolism and growth of rat glioma cells (C6) in multicellular spheroid culture.
International journal of cancer. Journal international du cancer 1992;52(2):279-85.
-
1992: Pettersson O A; Carlsson J; Grusell E
Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Cancer research 1992;52(6):1587-91.
-
1992: Blomquist E; Carlsson J
Strategy for planned radiotherapy of malignant gliomas: postoperative treatment with combinations of high dose proton irradiation and tumor seeking radionuclides.
International journal of radiation oncology, biology, physics 1992;22(2):259-63.
-
1992: Carlsson J; Sjöberg S; Larsson B S
Present status of boron neutron capture therapy.
Acta oncologica (Stockholm, Sweden) 1992;31(8):803-13.
-
1991: Frykholm G; Glimelius B; Richter S; Carlsson J
Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1991;27A(12):900-6.
-
1991: Gáti I; Bergström M; Muhr C; Långström B; Carlsson J
Application of (methyl-11C)-methionine in the multicellular spheroid system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(12):2258-65.
-
1991: Capala J; Carlsson J
Influence of chloroquine and lidocaine on retention and cytotoxic effects of [131I]EGF: studies on cultured glioma cells.
International journal of radiation biology 1991;60(3):497-510.
-
1991: Oscarsson S; Carlsson J
Immunocomplex-immobilization technique.
The Analyst 1991;116(8):787-91.
-
1991: Gáti I; Bergström M; Muhr C; Carlsson J
Effects of the PAF-analog and -antagonist CV-6209 on cultured human glioma cell lines.
Prostaglandins, leukotrienes, and essential fatty acids 1991;43(2):103-10.
-
1991: Szolgay-Daniel E; Carlsson J; Zierold K; Holtermann G; Dufau E; Acker H
Effects of amiloride treatment on U-118 MG and U-251 MG human glioma and HT-29 human colon carcinoma cells.
Cancer research 1991;51(3):1039-44.
-
1991: Andersson A; Holmberg A; Carlsson J; Carlsson J; Pontén J; Westermark B
Binding of epidermal growth factor-dextran conjugates to cultured glioma cells.
International journal of cancer. Journal international du cancer 1991;47(3):439-44.
-
1991: Scott-Robson S; Capala J; Carlsson J; Malmborg P; Lundqvist H
Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(2):241-6.
-
1991: Rosengren B; Wulff L; Carlsson E; Carlsson J; Montelius A; Russell K; Grusell E
Backscatter radiation at tissue-titanium interfaces. Analyses of biological effects from 60Co and protons.
Acta oncologica (Stockholm, Sweden) 1991;30(7):859-66.
-
1991: Montelius A; Blomquist E; Naeser P; Brahme A; Carlsson J; Carlsson A C; Graffman S; Grusell E; Hallén S; Jakobsson P
The narrow proton beam therapy unit at the the Svedberg Laboratory in Uppsala.
Acta oncologica (Stockholm, Sweden) 1991;30(6):739-45.
-
1990: Capala J; Pråhl M; Scott-Robson S; Pontén J; Westermark B; Carlsson J
Effects of 131I-EGF on cultured human glioma cells.
Journal of neuro-oncology 1990;9(3):201-10.
-
1990: Gáti I; Bergström M; Csóka K; Muhr C; Carlsson J
Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines.
Prostaglandins, leukotrienes, and essential fatty acids 1990;40(2):117-24.
-
1990: Gàti I; Bergström M; Westerberg G; Csòka K; Muhr C; Carlsson J
Effects of prostaglandin and leukotriene inhibitors on the growth of human glioma spheroids.
European journal of cancer (Oxford, England : 1990) 1990;26(7):802-7.
-
1989: Nylén T; Acker H; Bölling B; Holterman G; Carlsson J
Influence of ionizing radiation on oxygen profiles in different types of multicellular spheroids.
Radiation research 1989;120(2):213-26.
-
1989: Carlsson J; Daniel-Szolgay E; Frykholm G; Glimelius B; Hedin A; Larsson B
Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.
Cancer immunology, immunotherapy : CII 1989;30(5):269-76.
-
1988: Carlsson J; Acker H
Relations between pH, oxygen partial pressure and growth in cultured cell spheroids.
International journal of cancer. Journal international du cancer 1988;42(5):715-20.
-
1987: Acker H; Carlsson J; Holtermann G; Nederman T; Nylén T
Influence of glucose and buffer capacity in the culture medium on growth and pH in spheroids of human thyroid carcinoma and human glioma origin.
Cancer research 1987;47(13):3504-8.
-
1983: Nederman T; Acker H; Carlsson J
Penetration of substances into tumor tissue: a methodological study with microelectrodes and cellular spheroids.
In vitro 1983;19(6):479-88.
-
1983: Acker H; Holtermann G; Carlsson J; Nederman T
Methodological aspects of microelectrode measurements in cellular spheroids.
Advances in experimental medicine and biology 1983;159():445-62.
Sign-in to see more
